SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-044889
Filing Date
2021-02-16
Accepted
2021-02-16 16:14:08
Documents
14
Period of Report
2021-02-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d126979d8k.htm   iXBRL 8-K 26126
2 EX-3.1 d126979dex31.htm EX-3.1 118194
3 EX-3.2 d126979dex32.htm EX-3.2 128868
  Complete submission text file 0001193125-21-044889.txt   459770

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrx-20210212.xsd EX-101.SCH 3063
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20210212_lab.xml EX-101.LAB 18124
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20210212_pre.xml EX-101.PRE 11400
7 EXTRACTED XBRL INSTANCE DOCUMENT d126979d8k_htm.xml XML 3456
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 21638557
SIC: 2834 Pharmaceutical Preparations